Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis
…, P Kokkoris, D Chatzifotiadis… - Clinical …, 2013 - Wiley Online Library
Objective Denosumab is a new potent antiresorptive treatment of osteoporosis that can
potentially induce a compensatory increase in parathyroid hormone ( PTH ) levels. We aimed to …
potentially induce a compensatory increase in parathyroid hormone ( PTH ) levels. We aimed to …
Assessment of interobserver reproducibility in quantitative 18F-FDG PET and CT measurements of tumor response to therapy
…, S Leboulleux, S Baba, D Chatzifotiadis… - Journal of Nuclear …, 2009 - Soc Nuclear Med
Our goal was to estimate and compare across different readers the reproducibility of the 18 F-FDG
PET standardized uptake value (SUV) and CT size measurements, and changes in …
PET standardized uptake value (SUV) and CT size measurements, and changes in …
Positron emission tomography and cancer
DN Chatzifotiadis, JW Buchanan, RL Wahl - Oncology: An Evidence …, 2006 - Springer
Positron emission tomography, PET, is a potent imaging tool in the management of a diverse
array of cancers. This chapter briefly discusses the rationale for PET imaging and describes …
array of cancers. This chapter briefly discusses the rationale for PET imaging and describes …
Importance of the same or different readers pre-and post-therapy for anatomic vs. metabolic response assessments
H Jacene, S Leboulleux, S Baba, D Chatzifotiadis… - 2011 - Soc Nuclear Med
1773 Objectives To compare inter-rater agreement of anatomic and metabolic response
assessments when quantitative measurements of tumor size and metabolism are determined by …
assessments when quantitative measurements of tumor size and metabolism are determined by …
Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose.
HC Steinert, RA Huch Böni, A Buck, R Böni, T Berthold… - Radiology, 1995 - pubs.rsna.org
PURPOSE: To evaluate whole-body positron emission tomography (PET) with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose
(FDG) in the detection of metastasis from melanoma. …
(FDG) in the detection of metastasis from melanoma. …
[BOOK][B] An evidence-based approach
Preface xiii new textbook in oncology?! What is different about this book compared to other
established texts that have already been published? Why do we need a new book? For …
established texts that have already been published? Why do we need a new book? For …
Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.
RL Wahl, LE Quint, RL Greenough, CR Meyer, RI White… - Radiology, 1994 - pubs.rsna.org
PURPOSE: To evaluate use of positron emission tomography (PET) with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose
(FDG) in detection of mediastinal lymph node metastases from non-…
(FDG) in detection of mediastinal lymph node metastases from non-…
Metastases from non-small cell lung cancer: mediastinal staging in the 1990s—meta-analytic comparison of PET and CT
BA Dwamena, SS Sonnad, JO Angobaldo, RL Wahl - Radiology, 1999 - pubs.rsna.org
PURPOSE: To meta-analytically compare 2-[fluorine 18]fluoro-2-deoxy-d-glucose positron
emission tomography (PET) and computed tomography (CT) for the demonstration of …
emission tomography (PET) and computed tomography (CT) for the demonstration of …
Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis
PURPOSE: To perform a meta-analysis to compare current noninvasive imaging methods (ultrasonography
[US], computed tomography [CT], magnetic resonance [MR] imaging, and 18 …
[US], computed tomography [CT], magnetic resonance [MR] imaging, and 18 …
Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience
PB Hathaway, DA Mankoff, KR Maravilla… - Radiology, 1999 - pubs.rsna.org
PURPOSE: To assess the performance and potential clinical effects of combined 2-[fluorine
18]fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET) and magnetic …
18]fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET) and magnetic …